| |
Original Artikel |
Journal |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
Future Medicinal Chemistry |
2024―Mai―17 |
Development of a Deep Learning-Based Quantitative Structure-Activity Relationship Model to Identify Potential Inhibitors Against the 3C-like Protease of SARS-CoV-2 |
Madhulata Kumari, Naidu Subbarao |
| 2 |
[GO] |
Future Medicinal Chemistry |
2024―Apr―15 |
Design, synthesis and biological evaluation of novel 3C-like protease inhibitors as lead compounds against SARS-CoV-2 |
Yong Yan, Hanwen Liu, Di Wu, Zhihao Gu, Wenhao Guo, Hequan Yao, Kejiang Lin, Xuanyi Li |
| 3 |
[GO] |
Future Medicinal Chemistry |
2023―Jul―12 |
Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main protease inhibitors |
Vinícius Gonçalves Maltarollo, Elany Barbosa da Silva, Thales Kronenberger, Marina Mol Sena Andrade, Gabriel V de Lima Marques, Nereu J Cândido Oliveira, Lucianna H Santos, Celso de Oliveira Rezende Júnior, Ana C Cassiano Martinho, Danielle Skinner, Pavla Fajtová, Thaís H M Fernandes, Eduardo da Silveira dos Santos, Poliana A Rodrigues Gazolla, Ana P Martins de Souza, Milene Lopes da Silva, Fabíola S dos Santos, Stefânia N Lavorato, Ana C Oliveira Bretas, Diogo Teixeira Carvalho, Lucas Lopardi Franco, Stephanie Luedtke, Miriam A Giardini, Antti Poso, Luiz C Dias, Larissa M Podust, Ricardo J Alves, James McKerrow, Saulo F Andrade, Róbson R Teixeira, Jair L Siqueira-Neto, Anthony O’Donoghue, Renata B de Oliveira, Rafaela S Ferreira |
| 4 |
[GO] |
Bioanalysis |
2023―Jun―06 |
Comparison of requirements for clinical study of SARS-CoV-2 antigen test kits in China, the USA and Europe |
Yunfeng Lyu, Yuting Zhu, Ying Zhang, Yuanyuan Hou, Yining Zhang, Jingyun He, Gang Deng |
| 5 |
[GO] |
Therapeutic Delivery |
2023―Apr―03 |
Updated landscape of inhaled medications to combat COVID-19 |
Mural Quadros, Vivek Gupta |
| 6 |
[GO] |
Future Medicinal Chemistry |
2023―Mrz―31 |
Truth and lies about the use of old drugs against COVID-19: have we learned the lesson? |
Carmine Iorio, Giuseppe Manfroni |
| 7 |
[GO] |
Future Medicinal Chemistry |
2023―Feb―03 |
The connection between PARP14 and SARS-CoV-2 |
Amanda L Tauber, Stephanie S Schweiker, Stephan M Levonis |
| 8 |
[GO] |
Pharmaceutical Patent Analyst |
2022―Okt―31 |
Exploring risks of investor claims brought forth after the TRIPS waiver for COVID-19 |
Shrikant Kulkarni, Varinder Kaur |
| 9 |
[GO] |
Pharmaceutical Patent Analyst |
2022―Mai―31 |
Remdesivir: an overview of patenting trends, clinical evidence on COVID-19 treatment, pharmacology and chemistry |
Sandro G Viveiros Rosa, Wilson C Santos |
| 10 |
[GO] |
Future Medicinal Chemistry |
2022―Mai―10 |
Therapeutic potential of vitamin B1 derivative benfotiamine from diabetes to COVID-19 |
Kieran V Allowitz, John J Yoo, Justin R Taylor, Omar A Baloch, Kyra Harames, Kota V Ramana |
| 11 |
[GO] |
Future Medicinal Chemistry |
2022―Mrz―22 |
Targeting mucin hypersecretion in COVID-19 therapy |
Parteek Prasher, Mousmee Sharma |
| 12 |
[GO] |
Future Medicinal Chemistry |
2022―Feb―27 |
Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening |
Li-chuan Zhang, Hui-lin Zhao, Jin Liu, Lei He, Ri-lei Yu, Cong-min Kang |
| 13 |
[GO] |
Therapeutic Delivery |
2022―Feb―23 |
SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments |
Adedapo Adesokan, Mohammad A. Obeid, Aisha F Lawal |
| 14 |
[GO] |
Bioanalysis |
2022―Feb―21 |
China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents |
Yunfeng Lv, Yu Gao, Jingyun He, Chao Xu, Rongzhi Liu, Shengwei Zheng, Li Fang, Congyin Han, Ran Li |
| 15 |
[GO] |
Future Drug Discovery |
2022―Feb―08 |
Breakthrough medicines during the COVID-19 pandemic era |
Eswara Naga Hanuma Kumar Ghali, Vijian Dhevan, Shravan K Narmala, Meena Jaggi, Subhash C Chauhan, Murali M Yallapu |
| 16 |
[GO] |
Future Medicinal Chemistry |
2021―Nov―24 |
Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening |
Abdulrahim R Hakami, Ahmed H Bakheit, Abdulrahman A Almehizia, Mohammed Y Ghazwani |
| 17 |
[GO] |
Bioanalysis |
2021―Nov―22 |
Special Focus Issue - COVID-19: bioanalytical considerations, contributions and lessons - part 2 |
Chad J Briscoe, Matthew Barfield |
| 18 |
[GO] |
Bioanalysis |
2021―Nov―18 |
Testing in the workplace: finding a path through a pandemic |
Jameson Briscoe |
| 19 |
[GO] |
Bioanalysis |
2021―Nov―15 |
Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China |
Hongran Li, Tong Jiao, Peirong Wang, Juanjuan An, Gang Deng, Lei Sun, Jinchun Dong |
| 20 |
[GO] |
Therapeutic Delivery |
2021―Nov―02 |
Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics |
Dingjiang Liu, Mohammed Shameem |
| 21 |
[GO] |
Therapeutic Delivery |
2021―Okt―21 |
The latest developments in the area of therapeutic delivery excluding some diseases, such as COVID-19 and the big three (HIV/AID, malaria and tuberculosis) |
Catarina Pinto Reis |
| 22 |
[GO] |
Bioanalysis |
2021―Okt―14 |
Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective |
Jeremy Baldwin, Sakshi Piplani, Isaac G Sakala, Yoshikazu Honda-Okubo, Lei Li, Nikolai Petrovsky |
| 23 |
[GO] |
Bioanalysis |
2021―Sep―13 |
Deploying a rapid point of care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety |
Radboud van Trigt, Jason Neat, Jan Leendert Brouwer, Amanda Hays, Hans Westerhof |
| 24 |
[GO] |
Future Medicinal Chemistry |
2021―Sep―02 |
COVID-19 diagnostic assays sensitivity: lessons for the upcoming wave or next pandemic |
Nikhil Shri Sahahjpal, Ashis K Mondal, Sudha Ananth, Kimya Jones, Alka Chaubey, Ravindra Kolhe |
| 25 |
[GO] |
Bioanalysis |
2021―Aug―31 |
Volumetric absorptive microsampling: its use in COVID-19 research and testing |
James Rudge, Stuart Kushon |
| 26 |
[GO] |
Bioanalysis |
2021―Aug―31 |
A minireview on nanoparticle-based sensors for detection of coronaviruses |
Elaheh Rahimpour, Farzaneh Lotfipour, Abolghasem Jouyban |
| 27 |
[GO] |
Bioanalysis |
2021―Aug―18 |
Special Focus Issue - COVID-19: bioanalytical considerations, contributions and lessons - part 1 |
Sankeetha Nadarajah |
| 28 |
[GO] |
Bioanalysis |
2021―Aug―10 |
COVID-19’s impact on bioanalytical labs |
Amy Lavelle, Janine Micheli |
| 29 |
[GO] |
Bioanalysis |
2021―Aug―06 |
Efficiency of pooled surveillance testing in academic labs to detect and inhibit COVID-19 outbreaks |
John C Sitko, James Jordan Steel, Erin A Almand, Christopher A Cullenbine, Joseph W Rohrer, Douglas P Wickert, Steven CM Hasstedt |
| 30 |
[GO] |
Bioanalysis |
2021―Jul―22 |
Detection of SARS-CoV-2 at the point of care |
Michael J Loeffelholz, Yi-Wei Tang |
| 31 |
[GO] |
Bioanalysis |
2021―Jul―21 |
Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic |
Trieu Nguyen, Anders Wolff |
| 32 |
[GO] |
Bioanalysis |
2021―Jul―19 |
How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis |
Melanie Anderson |
| 33 |
[GO] |
Bioanalysis |
2021―Jul―19 |
Lessons learned from the COVID pandemic and its impact on bioanalysis and drug development |
Enaksha R Wickremsinhe, Catherine L Brockus, Anthony T Murphy |
| 34 |
[GO] |
Future Medicinal Chemistry |
2021―Jun―25 |
Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors |
M Elizabeth Sobhia, G Siva Kumar, Srikanth Sivangula, Ketan Ghosh, Harmanpreet Singh, Thongtinlal Haokip, Joseph Gibson |
| 35 |
[GO] |
Future Medicinal Chemistry |
2021―Jun―25 |
Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening |
Leonardo Bruno Federico, Guilherme Martins Silva, Lorane Izabel da Silva Hage-Melim, Suzane Quintana Gomes, Mariana Pegrucci Barcelos, Isaque Antônio Galindo Francischini, Carlos Henrique Tomich de Paula da Silva |
| 36 |
[GO] |
Therapeutic Delivery |
2021―Apr―07 |
Therapeutic potential of inhalable medications to combat coronavirus disease-2019 |
Vineela Parvathaneni, Nishant S Kulkarni, Aaron Muth, Nitesh K Kunda, Vivek Gupta |
| 37 |
[GO] |
Therapeutic Delivery |
2021―Feb―24 |
An overview of vaccine development for COVID-19 |
Seyed H Shahcheraghi, Jamshid Ayatollahi, Alaa AA Aljabali, Madhur D Shastri, Shakti D Shukla, Dinesh K Chellappan, Niraj K Jha, Krishnan Anand, Naresh K Katari, Meenu Mehta, Saurabh Satija, Harish Dureja, Vijay Mishra, Abdulmajeed G Almutary, Abdullah M Alnuqaydan, Nitin Charbe, Parteek Prasher, Gaurav Gupta, Kamal Dua, Marzieh Lotfi, Hamid A Bakshi, Murtaza M Tambuwala |
| 38 |
[GO] |
Future Medicinal Chemistry |
2021―Feb―16 |
De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence |
Navneet Bung, Sowmya R Krishnan, Gopalakrishnan Bulusu, Arijit Roy |
| 39 |
[GO] |
Bioanalysis |
2021―Feb―04 |
Adaptation of Elecsys® anti-severe acute respiratory syndrome coronavirus-2 immunoassay to dried blood spots: proof of concept |
Alexandre Marchand, Ingrid Roulland, Florian Semence, Magnus Ericsson |
| 40 |
[GO] |
Future Medicinal Chemistry |
2021―Jan―20 |
The potential association between PARP14 and the SARS-CoV-2 infection (COVID-19) |
Amanda L Tauber, Stephanie S Schweiker, Stephan M Levonis |
| 41 |
[GO] |
Pharmaceutical Patent Analyst |
2021―Jan―15 |
Repurposing drugs during the COVID-19 pandemic and beyond |
Srividya Ravi, Sammita Jadhav, Anuradha Vaidya, Ravindra Ghooi |
| 42 |
[GO] |
Bioanalysis |
2021―Jan―11 |
Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests |
Hongran Li, Jingyun He, Wen Bao, Peirong Wang, Yunfeng Lv, Chao Xu, Peng Hu, Yu Gao, Shengwei Zheng, Juanjuan An, Gang Deng, Jinchun Dong |
| 43 |
[GO] |
Future Medicinal Chemistry |
2021―Jan―08 |
Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product database |
Jurica Novak, Hrvoje Rimac, Shivananda Kandagalla, Maria A Grishina, Vladimir A Potemkin |
| 44 |
[GO] |
Bioanalysis |
2020―Dez―16 |
China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval |
Yunfeng Lv, Jingyun He, Rongzhi Liu, Yu Gao, Chao Xu, Peng Hu, Shengwei Zheng, Li Fang, Ran Li, Congyin Han, Juanjuan An, Jinchun Dong |
| 45 |
[GO] |
Bioanalysis |
2020―Dez―15 |
Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays |
Theodore T Zava, David T Zava |
| 46 |
[GO] |
Future Drug Discovery |
2020―Dez―15 |
COVID-19 vaccines: challenges and promises of trials, manufacturing and allocation of doses |
Benedetta Spadaro |
| 47 |
[GO] |
Future Drug Discovery |
2020―Dez―03 |
High-throughput approaches of diagnosis and therapies for COVID-19: antibody panels, proteomics and metabolomics |
Rwik Sen |
| 48 |
[GO] |
Future Medicinal Chemistry |
2020―Nov―24 |
COVID-19 screening in a healthcare or community setting: complexity of saliva as a specimen for PCR-based testing |
Nikhil Shri Sahajpal, Ashis K Mondal, Allan Njau, Sudha Ananth, Salil Ghamande, Madhuri Hegde, Alka Chaubey, Amyn M Rojiani, Ravindra Kolhe |
| 49 |
[GO] |
Future Drug Discovery |
2020―Okt―01 |
Withania somnifera as a potential future drug molecule for COVID-19 |
Vivek K Kashyap, Anupam Dhasmana, Murali M Yallapu, Subhash C Chauhan, Meena Jaggi |
| 50 |
[GO] |
Bioanalysis |
2020―Sep―11 |
How ADA methodology informs SARS-CoV-2 assay development |
Caroline Becker |
| 51 |
[GO] |
Bioanalysis |
2020―Aug―21 |
Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients |
Zhuo Chen, Timothy W Sikorski |
| 52 |
[GO] |
Future Medicinal Chemistry |
2020―Aug―13 |
Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study |
Witor Ribeiro Ferraz, Renan Augusto Gomes, Andre Luis S Novaes, Gustavo Henrique Goulart Trossini |
| 53 |
[GO] |
Bioanalysis |
2020―Jul―31 |
Could breath analysis by MS could be a solution to rapid, non-invasive testing for COVID-19? |
Heather J Walker, Michael M Burrell |
| 54 |
[GO] |
Future Medicinal Chemistry |
2020―Jul―16 |
Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics |
Sonya VanPatten, Mingzhu He, Ahmad Altiti, Kai F Cheng, Mustafa H Ghanem, Yousef Al-Abed |
| 55 |
[GO] |
Future Medicinal Chemistry |
2020―Jul―08 |
Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2 |
Shiyong Fan, Dian Xiao, Yanming Wang, Lianqi Liu, Xinbo Zhou, Wu Zhong |
| 56 |
[GO] |
Therapeutic Delivery |
2020―Jun―29 |
The potential role of nanomedicine on COVID-19 therapeutics |
Rubiana Mara Mainardes, Camila Diedrich |
| 57 |
[GO] |
Future Medicinal Chemistry |
2020―Jun―26 |
Vesicular drug-delivery systems as theranostics in COVID-19 |
Saurabh Satija, Meenu Mehta, Mousmee Sharma, Parteek Prasher, Gaurav Gupta, Dinesh K Chellappan, Kamal Dua |
| 58 |
[GO] |
Bioanalysis |
2020―Jun―26 |
Bioanalytical research and training in academia during the COVID-19 pandemic |
Frank Klont, Gérard Hopfgartner |
| 59 |
[GO] |
Bioanalysis |
2020―Jun―23 |
Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience |
Emirena Garrafa, Duilio Brugnoni, Mosè Barbaro, Laura Andreoli, Emanuele Focà, Massimo Salvetti, Francesco Castelli, Franco Franceschini, Simone Piva, Maria Lorenza Muiesan, Nicola Latronico, Rosella Levaggi |
| 60 |
[GO] |
Future Medicinal Chemistry |
2020―Jun―22 |
Tackling SARS-CoV-2: proposed targets and repurposed drugs |
Siddhi Joshi, Maithili Joshi, Mariam S Degani |
| 61 |
[GO] |
Future Medicinal Chemistry |
2020―Jun―19 |
Role of clinical laboratories in response to the COVID-19 pandemic |
Nikhil Shri Sahajpal, Allan Njau, Ashis K Mondal, Sudha Ananth, Alka Chaubey, Amyn Rojiani, Ravindra Kolhe |
| 62 |
[GO] |
Bioanalysis |
2020―Jun―12 |
Virtual drug testing: redefining sample collection in a global pandemic |
Matthew N Fedoruk |
| 63 |
[GO] |
Future Drug Discovery |
2020―Mai―27 |
Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2 |
Suranga L Senanayake |
| 64 |
[GO] |
Bioanalysis |
2020―Mai―26 |
Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond |
Sumit Kar, Rafiqul Islam |
| 65 |
[GO] |
Therapeutic Delivery |
2020―Mai―13 |
COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics |
Haneen Amawi, Ghina'a I Abu Deiab, Alaa A A Aljabali, Kamal Dua, Murtaza M Tambuwala |
| 66 |
[GO] |
Bioanalysis |
2020―Apr―15 |
Exhaled breath condensate as a potential specimen for diagnosing COVID-19 |
Maryam Khoubnasabjafari, Vahid Jouyban-Gharamaleki, Reza Ghanbari, Abolghasem Jouyban |
| 67 |
[GO] |
Bioanalysis |
2020―Apr―14 |
Managing bioanalytical studies during the COVID-19 pandemic: an overview |
Peter Pruim, Naomi Teekamp |
| 68 |
[GO] |
Future Drug Discovery |
2020―Mrz―25 |
Drug repurposing strategies for COVID-19 |
Suranga L Senanayake |
